Acute effects of sarpogrelate, a 5-HT2A receptor antagonist on cytokine production in endotoxin shock model of rats

被引:16
|
作者
Nishiyama, Tomoki [1 ]
机构
[1] Kamagaya Gen Hosp, Dept Anesthesiol & Crit Care, Chiba 2730121, Japan
关键词
Serotonin (5-HT)(2A) receptor; Endotoxin shock; Cytokine; Lung injury; TUMOR-NECROSIS-FACTOR; SEPTIC SHOCK; SEROTONIN; INTERLEUKIN-6; BINDING; SEPSIS; IDENTIFICATION; INVOLVEMENT; SUBTYPES; CELLS;
D O I
10.1016/j.ejphar.2009.03.041
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Serotonin (5-HT)(2A) receptors are involved in cytokine production in infection or sepsis. Therefore, 5-HT2A receptor antagonist might be useful to treat sepsis. The present study investigates the effects of a 5-HT2A receptor antagonist, sarpogrelate on endotoxin shock. Catheters were inserted into the femoral artery and vein of Sprague-Dawley rats. First, sarpogrelate 0 (control), 3, or 10 mg/kg dissolved in 0.5 ml of distilled water has been given, followed by endotoxin 10 mg/kg in saline 0.5 ml 5 min later. Blood pressure, pulse rate and survival rate were monitored in 20 rats per dose. Blood gas and plasma cytokine concentrations were measured in 8 rats per dose. In four rats each of sarpogrelate 0, 3, or 10 mg/kg, and sham operation, the lung histology was examined. Zero, 15, and 12 rats survived for 8 h in the control. 3 mg/kg, and 10 mg/kg groups, respectively. The control group had the lowest blood pressure, pulse rate, pH and arterial oxygen tension, and the highest arterial carbon dioxide tension and plasma IL-1 beta concentration. The increase of TNF-alpha was significantly lower in 3 mg/kg group than in the control group. Pathological changes of the lung were inhibited in 3 and 10 mg/kg groups. In conclusion, sarpogrelate might be effective to decrease production of pro-inflammatory cytokines, to keep hemodynamics, to inhibit lung damage, and to decrease mortality in endotoxin shock. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 50 条
  • [1] Beneficial Effects of Sarpogrelate Hydrochloride, a 5-ht2a Receptor Antagonist, Supplemented with Pioglitazone on Diabetic Model Mice
    Iizuka, Kenji
    Hamaue, Naoya
    Machida, Takuji
    Hirafuji, Masahiko
    Tsuji, Masahiro
    ENDOCRINE RESEARCH, 2009, 34 (1-2) : 18 - 30
  • [2] Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy
    Tullis, Brandon E.
    Ryals, Renee C.
    Coyner, Aaron S.
    Gale, Michael J.
    Nicholson, Alex
    Ku, Cristy
    Regis, Dain
    Sinha, Wrik
    Datta, Shreya
    Wen, Yuquan
    Yang, Paul
    Pennesi, Mark E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (08) : 4560 - 4569
  • [3] Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats
    Hashizume, Hiroshi
    Kawakami, Mamoru
    Yoshida, Munehito
    Okada, Motohiro
    Enyo, Yoshio
    Inomata, Yuji
    SPINE, 2007, 32 (03) : 315 - 320
  • [4] Effect of 5-HT2A receptor antagonist ketanserin on micturition in male rats
    Wang Xiaohua
    Cao Nailong
    Ni Jianshu
    Si Jiemin
    Gu Baojun
    Karl-Erik, Andersson
    NEUROSCIENCE LETTERS, 2018, 687 : 196 - 201
  • [5] Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model
    Miyata, K
    Shimokawa, H
    Higo, T
    Yamawaki, T
    Katsumata, N
    Kandabashi, T
    Tanaka, E
    Takamura, Y
    Yogo, K
    Egashira, K
    Takeshita, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (02) : 294 - 301
  • [6] Antagonist Functional Selectivity: 5-HT2A Serotonin Receptor Antagonists Differentially Regulate 5-HT2A Receptor Protein Level In Vivo
    Yadav, Prem N.
    Kroeze, Wesley K.
    Farrell, Martilias S.
    Roth, Bryan L.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (01) : 99 - 105
  • [7] Deficits in LTP Induction by 5-HT2A Receptor Antagonist in a Mouse Model for Fragile X Syndrome
    Xu, Zhao-hui
    Yang, Qi
    Ma, Lan
    Liu, Shui-bing
    Chen, Guang-sheng
    Wu, Yu-mei
    Li, Xiao-qiang
    Liu, Gang
    Zhao, Ming-gao
    PLOS ONE, 2012, 7 (10):
  • [8] Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test
    Rahbarnia, Arya
    Li, Zhaoxia
    Fletcher, Paul J.
    PSYCHOPHARMACOLOGY, 2023,
  • [9] Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats
    Kehne, JH
    Ketteler, HJ
    McCloskey, TC
    Sullivan, CK
    Dudley, MW
    Schmidt, CJ
    NEUROPSYCHOPHARMACOLOGY, 1996, 15 (02) : 116 - 124
  • [10] CONSTRUCTION OF A DETAILED SEROTONINERGIC 5-HT2A RECEPTOR MODEL
    HOLTJE, HD
    JENDRETZKI, UK
    ARCHIV DER PHARMAZIE, 1995, 328 (7-8) : 577 - 584